Evaluation of the Radiolabeled Boronic Acid-Based FAP Inhibitor MIP-1232 for Atherosclerotic Plaque Imaging

@article{Meletta2015EvaluationOT,
  title={Evaluation of the Radiolabeled Boronic Acid-Based FAP Inhibitor MIP-1232 for Atherosclerotic Plaque Imaging},
  author={Romana Meletta and Adrienne M{\"u}ller Herde and A. Chiotellis and M. Isa and Z. Ran{\vc}i{\'c} and N. Borel and S. Ametamey and S. Kr{\"a}mer and R. Schibli},
  journal={Molecules},
  year={2015},
  volume={20},
  pages={2081 - 2099}
}
  • Romana Meletta, Adrienne Müller Herde, +6 authors R. Schibli
  • Published 2015
  • Chemistry, Medicine
  • Molecules
    • Research towards the non-invasive imaging of atherosclerotic plaques is of high clinical priority as early recognition of vulnerable plaques may reduce the incidence of cardiovascular events. The fibroblast activation protein alpha (FAP) was recently proposed as inflammation-induced protease involved in the process of plaque vulnerability. In this study, FAP mRNA and protein levels were investigated by quantitative polymerase chain reaction and immunohistochemistry, respectively, in human… CONTINUE READING
    View PDF
    9 Citations
    Background Citations
    3
    Methods Citations
    2
    9 Citations
    Citation Type

    Citation Type

    Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [11C]RS-016 targeting CB2 in atherosclerosis.
    • 17
    Design and validation of fibroblast activation protein alpha targeted imaging and therapeutic agents
    • 4
    • PDF
    Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications.
    • 3
    A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts
    • 69
    • PDF
    Brush border enzyme-cleavable linkers: Evaluation for reducing renal uptake of radiolabeled prostate-specific membrane antigen inhibitors.
    • 3
    Fibroblast activation protein regulates lesion burden and the fibro-inflammatory response in Apoe-deficient mice in a sexually dimorphic manner.
    • 1
    Novel Agents and Future Perspectives on Theranostics.
    The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy.
    • 1
    Targeting of activated fibroblasts for imaging and therapy
    • 18

    References

    SHOWING 1-10 OF 58 REFERENCES
    Imaging Atherosclerotic Plaque Inflammation via Folate Receptor Targeting Using a Novel 18F-Folate Radiotracer
    • 24
    Towards non-invasive imaging of vulnerable atherosclerotic plaques by targeting co-stimulatory molecules.
    • 30
    Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
    • 35
    In Vivo Molecular Imaging of Atherosclerotic Lesions in ApoE−/− Mice Using VCAM-1–Specific, 99mTc-Labeled Peptidic Sequences
    • 33
    • PDF
    Folate Receptor–Targeted Single-Photon Emission Computed Tomography/Computed Tomography to Detect Activated Macrophages in Atherosclerosis: Can It Distinguish Vulnerable from Stable Atherosclerotic Plaques?
    • 48
    Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography.
    • 198
    • PDF
    Radioimmunotherapy of Fibroblast Activation Protein Positive Tumors by Rapidly Internalizing Antibodies
    • 47
    • PDF
    Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque.
    • 95
    • PDF
    Molecular Imaging in Atherosclerosis: FDG PET
    • 48
    Clinical Implications of Fibroblast Activation Protein in Patients with Colon Cancer
    • 227
    • PDF